We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EDZ icon
4551
Direxion Daily MSCI Emerging Markets Bear 3X ETF
EDZ
$19.9M
$7K ﹤0.01%
98
-55
-36% -$4.46K
EMQQ icon
4552
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$275M
$7K ﹤0.01%
107
EPOW icon
4553
E-Power Inc
EPOW
$21.3M
$7K ﹤0.01%
1,909
-2,971
-61% -$9.01K
EZA icon
4554
iShares MSCI South Africa ETF
EZA
$579M
$7K ﹤0.01%
+140
New +$7.15K
LKFT
4555
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.76B
$7K ﹤0.01%
108
-1,686
-94% -$129K
HEPA
4556
DELISTED
Hepion Pharmaceuticals
HEPA
$7K ﹤0.01%
3
-22
-88% -$40.3K
JVA icon
4557
Coffee Holding Co
JVA
$19.9M
$7K ﹤0.01%
1,252
-236
-16% -$1.26K
NXDR
4558
Nextdoor Holdings
NXDR
$1.04B
$7K ﹤0.01%
+722
New +$7.3K
MIR icon
4559
Mirion Technologies
MIR
$3.75B
$7K ﹤0.01%
702
-11,051
-94% -$114K
NTNX icon
4560
Nutanix
NTNX
$17.4B
$7K ﹤0.01%
186
-343
-65% -$10.7K
NUVB icon
4561
Nuvation Bio
NUVB
$2.32B
$7K ﹤0.01%
785
+110
+16% +$1.25K
OBIO icon
4562
Orchestra BioMed
OBIO
$267M
$7K ﹤0.01%
692
+147
+27% +$1.52K
QUAL icon
4563
iShares MSCI USA Quality Factor ETF
QUAL
$48.1B
$7K ﹤0.01%
50
-481
-91% -$61.7K
RNGR icon
4564
Ranger Energy Services
RNGR
$388M
$7K ﹤0.01%
921
-1,580
-63% -$10.7K
SHBI icon
4565
Shore Bancshares
SHBI
$788M
$7K ﹤0.01%
443
-1,536
-78% -$26K
SLYG icon
4566
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.18B
$7K ﹤0.01%
82
SMHI icon
4567
SEACOR Marine Holdings
SMHI
$263M
$7K ﹤0.01%
1,532
+858
+127% +$3.79K
UGL icon
4568
ProShares Ultra Gold
UGL
$807M
$7K ﹤0.01%
500
UGP icon
4569
Ultrapar
UGP
$6.42B
$7K ﹤0.01%
1,844
-233
-11% -$902
VYM icon
4570
Vanguard High Dividend Yield ETF
VYM
$83.7B
$7K ﹤0.01%
65
-10
-13% -$1.05K
WGS icon
4571
GeneDx Holdings
WGS
$2.32B
$7K ﹤0.01%
15
+11
+275% +$4.72K
XENE icon
4572
Xenon Pharmaceuticals
XENE
$6.21B
$7K ﹤0.01%
389
-16
-4% -$295
ONIT
4573
Onity Group
ONIT
$326M
$7K ﹤0.01%
+235
New +$7.15K
HURA
4574
TuHURA Biosciences
HURA
$137M
$7K ﹤0.01%
+2
New +$5.75K
VIRX
4575
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$7K ﹤0.01%
641
-5,745
-90% -$57.6K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.